Press release
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Celiac Disease Treatment Market
Celiac Disease Treatment
Forecasted Expansion of the Celiac Disease Treatment Market Size Through 2029
The celiac disease treatment market is projected to grow robustly, reaching a value of $0.94 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. This upward trajectory is driven by several critical factors including the increasing global prevalence of celiac disease, higher rates of diagnosis and awareness, ongoing clinical trials aimed at developing novel therapies, and a rising preference for gluten-free products. Additionally, supportive regulatory policies for orphan diseases and growing healthcare investments are fueling this market's expansion. Significant trends expected to influence this market involve the adoption of innovative non-dietary therapies, progress in enzyme supplement formulations, personalized medicine approaches, advances in peptide-based immunotherapies, enhanced diagnostic technologies, and clinical trial improvements.
Download a free sample of the celiac disease treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Important Factors Contributing to Market Growth
A key factor boosting the celiac disease treatment market is the rising prevalence of the condition globally, which leads to greater demand for effective treatment options. Increased awareness and better diagnostic tools also contribute to more patients being identified and treated.
In addition, regulatory support for orphan diseases encourages investment in research and development, while healthcare spending on innovative treatments continues to grow. These elements collectively enhance the market's growth prospects over the forecast period.
View the full celiac disease treatment market report:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Top Companies Leading the Celiac Disease Treatment Market
Several prominent pharmaceutical and biotechnology companies dominate the competitive landscape of the celiac disease treatment market. These include Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, and ImmunogenX.
Collaborative Developments Advancing Treatment Options
In October 2022, Takeda Pharmaceutical Company Limited, headquartered in Japan, formed a partnership with Zedira GmbH and Dr. Falk Pharma to develop an innovative oral therapy called TAK-227 (ZED1227). This treatment targets intestinal repair and inflammation, offering a promising approach for managing celiac disease. Zedira GmbH is a German biotechnology firm specializing in treatments for celiac disease and related transglutaminase conditions, while Dr. Falk Pharma, also based in Germany, focuses on gastrointestinal disorder medications.
Emerging Focus on Oral Therapies in Celiac Disease Treatment
Leading companies in the celiac disease arena are increasingly concentrating on developing oral therapies, particularly small molecule drugs. These therapies aim to provide targeted relief by blocking immune reactions to gluten, which helps improve treatment adherence and offers alternatives to strict gluten-free diets. Small molecule therapies are designed to enter cells easily and modulate disease-causing proteins or enzymes.
For example, in February 2025, the US biotech company Immunic Inc. introduced IMU-856, a small molecule that elevates endogenous glucagon-like peptide-1 (GLP-1) levels. This action improves intestinal barrier function in patients with celiac disease, enhances nutrient absorption, and alleviates symptoms without suppressing immune responses.
Detailed Breakdown of the Celiac Disease Treatment Market Segmentation
This market is segmented based on treatment type, enzyme type, diagnosis method, and distribution channel, providing a comprehensive view of patient management approaches.
By Treatment Type:
- Vitamins and Minerals
- Gluten Degrading Enzymes
- Symptomatic Treatment
- Other Treatments
By Enzyme Type:
- Distension
- Diarrhoea
- Anorexia
- Bloating
- Gas
- Fatigue
By Diagnosis Method:
- Serological Tests
- Genetic Testing
- Biopsy
By Distribution Channel:
- Hospitals
- Research Centres
- Clinics
- Other Distribution Channels
Further subcategories under vitamins and minerals include iron supplements, calcium supplements, vitamin D, vitamin B12, and multivitamins. Gluten-degrading enzymes are divided into endopeptidases, exopeptidases, and combination enzyme formulations. Symptomatic treatments cover antidiarrheal medications, antidepressants, anti-inflammatory drugs, and immunosuppressive agents. Other treatments include probiotics, immunotherapy, stem cell therapy, and experimental therapies.
This detailed segmentation highlights the variety of approaches being researched and used to manage celiac disease, reflecting the complexity and personalized nature of treatment in this field.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Celiac Disease Treatment Market here
News-ID: 4318671 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
